Information Request Form

Please enter your message in the form below. Your message will be emailed directly to the contact associated with the press release upon the submission of the form.

Press Release:
FDA Accepts for Review Theravance's Complete Response Submission for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Press Release Date:
04/24/2009 04:05 PM Eastern Time
Your Email Address: (Required)
Subject Line: (Required)
Your Name:
Your Title:
Your Company/Publication Name:
Your Message: (Required)

Information entered into this form will be relayed, solely to the Marketwire client contact that is associated with this release. Your privacy is important to us, and we make sure it is properly protected. Please see our privacy policy for more details.